pyrazinamide has been researched along with Disease in 1 studies
pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.
Disease: A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| CORDICE, JW | 1 |
| HILL, LM | 1 |
| WRIGHT, LT | 1 |
1 other study available for pyrazinamide and Disease
| Article | Year |
|---|---|
Use of pyrazinamide (aldinamide) in the treatment of tuberculous lymphadenopathy and draining sinuses; a preliminary report.
Topics: Disease; Humans; Lymph Nodes; Niacin; Nicotinic Acids; Pyrazinamide; Sternum; Tuberculosis; Tubercul | 1953 |